288617-58-3

Basic information

• Product Name: (E)-4-{4-[2-(N-Benzyloxycarbonyl-N-methylamino)ethoxy]phenyl}-3,4-diphenyl-3-buten-2-ol
• Synonyms: (E)-4-{4-[2-(N-Benzyloxycarbonyl-N-methylamino)ethoxy]phenyl}-3,4-diphenyl-3-buten-2-ol
• CAS NO: 288617-58-3
• Molecular Weight: 507.629
• Mol File: 288617-58-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (E)-4-{4-[2-(N-Benzyloxycarbonyl-N-methylamino)ethoxy]phenyl}-3,4-diphenyl-3-buten-2-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-4-{4-[2-(N-Benzyloxycarbonyl-N-methylamino)ethoxy]phenyl}-3,4-diphenyl-3-buten-2-ol(288617-58-3)
• EPA Substance Registry System: (E)-4-{4-[2-(N-Benzyloxycarbonyl-N-methylamino)ethoxy]phenyl}-3,4-diphenyl-3-buten-2-ol(288617-58-3)

Safety Data

• Hazardous Substances Data: 288617-58-3(Hazardous Substances Data)

Upstream product

• 501-53-1 benzyl chloroformate 
• 162070-61-3 alpha-Hydroxy-N-desmethyltamoxifen 
• 288617-57-2 (E)-4-{4-[2-(N-Ethoxycarbonyl-N-methylamino)ethoxy]phenyl}-3,4-diphenyl-3-buten-2-ol 
• 97151-02-5 (E)-(+/-)-alpha-Hydroxytamoxifen 

Downstream Products

• 743458-14-2 9-{(2R,4S,5R)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-tetrahydro-furan-2-yl}-2-{(E)-1-methyl-3-[4-(2-methylamino-ethoxy)-phenyl]-2,3-diphenyl-allylamino}-1,9-dihydro-purin-6-one 
• 743458-12-0 {2-[4-((E)-3-Amino-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-methyl-carbamic acid benzyl ester 
• 743458-11-9 (2-{4-[(E)-3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-1,2-diphenyl-but-1-enyl]-phenoxy}-ethyl)-methyl-carbamic acid benzyl ester 
• 288617-59-4 (E)-2-Acetoxy-4-{4-[2-(N-benzyloxycarbonyl-N-methylamino)ethoxy]phenyl}-3,4-diphenyl-3-butene 

Relevant articles and documents

Synthesis of oligodeoxynucleotides containing a single diastereoisomer of α-(N2-2′-deoxyguanosinyl)-N-desmethyltamoxifen

A phosphoramidite chemical synthesis of oligodeoxynucleotides containing a diastereoisomer of (E)-α-(N2-deoxyguanosinyl)-N- desmethyltamoxifen, a major tamoxifen (TAM)-derived DNA adduct in animal and women treated with TAM, was described. The